Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Acute Leukaemia and Myelodysplastic Syndrome

NCT03014934 is registered in ClinicalTrials.gov with European Society for Blood and Marrow Transplantation as lead sponsor.

NCT NCT03014934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03014934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Pre-existing Invasive Aspergillosis on Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Acute Leukaemia and Myelodysplastic Syndrome
Lead sponsor
European Society for Blood and Marrow Transplantation
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2021
Enrollment
2,100 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

invasive aspergillosis